SEARCH

SEARCH BY CITATION

References

  • Berendt, M., Gredal, H., Ersboll, A.K. & Alving, J. (2007) Premature death, risk factors, and life patterns in dogs with epilepsy. Journal of Veterinary Internal Medicine, 21, 754759.
  • Bostom, A.G., Kronenberg, F. & Ritz, E. (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. Journal of the American Society of Nephrology, 13, 21402144.
  • Dayrell-Hart, B., Steinberg, S.A., VanWinkle, T.J. & Farnbach, G.C. (1991) Hepatotoxicity of phenobarbital in dogs: 18 cases (1985–1989). Journal of the American Veterinary Medical Association, 199, 10601066.
  • European Agency for the Evaluation of Medicinal Products (EMEA) (2004). Guideline on procedures for competent authorities for pharmacovigilance information for veterinary medicinal products. Committee for Veterinary Medicinal Products (CVMP). EMEA/CVMP/345/98-Rev. 1-FINAL. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004997.pdf
  • European Medicines Agency (2011). Combined VeDDRA list of clinical terms for reporting suspected adverse reactions in animals and humans to veterinary medicinal products. EMA/CVMP/10418/2009-Rev.3. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/07/WC500094802.pdf
  • European Medicines Agency (2012) CVMP Assessment Report for Pexion® (imepitoin) (EMEA/V/C/002543/0000), http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/veterinary/002543/WC500140842.pdf (date last accessed: 5 April 2013).
  • Frey, H.H. & Löscher, W. (1985) Pharmacokinetics of anti-epileptic drugs in the dog: a review. Journal of Veterinary Pharmacology and Therapeutics, 8, 219233.
  • Frey, H.H. & Schwartz-Porsche, D. (1985) Pharmacologic principles in the treatment of epilepsy in the dog and cat. Tierarztliche Praxis, 13, 541549.
  • Fukunaga, K., Saito, M., Matsuo, E., Muto, M., Mishima, K., Fujiwara, M. & Orito, K. (2009) Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs. Research in Veterinary Science, 87, 455457.
  • Gaskill, C.L., Miller, L.M., Mattoon, J.S., Hoffmann, W.E., Burton, S.A., Gelens, H.C., Ihle, S.L., Miller, J.B., Shaw, D.H. & Cribb, A.E. (2005) Liver histopathology and liver and serum alanine aminotransferase and alkaline phosphatase activities in epileptic dogs receiving phenobarbital. Veterinary Pathology, 42, 147160.
  • Graham, R.A., Downey, A., Mudra, D., Krueger, L., Carroll, K., Chengelis, C., Madan, A. & Parkinson, A. (2002) In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs. Drug Metabolism and Disposition, 30, 12061213.
  • von Klopmann, T., Rambeck, B. & Tipold, A. (2007) Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of Small Animal Practice, 48, 134138.
  • Löscher, W. (1993) Basic aspects of epilepsy. Current Opinion in Neurology and Neurosurgery, 6, 223232.
  • Löscher, W. (1994) Neue Antiepileptika - ein Fortschritt für die Behandlung epileptischer Tiere. Kleintierpraxis, 39, 325342.
  • Löscher, W. (2003) Pharmakologische Grundlagen zur Behandlung der Epilepsie bei Hund und Katze. Praktischer Tierarzt, 84, 574587.
  • Löscher, W., Schwartz-Porsche, D., Frey, H.H. & Schmidt, D. (1985) Evaluation of epileptic dogs as an animal model of human epilepsy. Arzneimittel-Forschung, 35, 8287.
  • Löscher, W., Potschaka, H., Rieck, S., Tipold, A. & Rundfeldt, C. (2004) Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia, 45, 12281239.
  • Löscher, W., Hoffmann, K., Twele, F., Potschka, H. & Töllner, K. (2013) The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs. Pharmacological Research, 77, 3946.
  • Mariani, C.L. (2013) Terminology and classification of seizures and epilepsy in veterinary patients. Topics in Companion Animal Medicine, 28, 3441.
  • Oberbauer, A.M., Grossmann, D.I., Irion, D.N., Schaffer, A.L., Eggleston, M.L. & Famula, T.R. (2003) The genetics of epilepsy in the Belgian Tervuren and sheep dog. Journal of Heredity, 94, 5763.
  • Patterson, E.N. (2013) Epileptogenesis and companion animals. Topics in Companion Animal Medicine, 28, 4245.
  • Podell, M. (1996) Seizures in dogs. Veterinary Clinics of North America: Small Animal Practice, 26, 779809.
  • Podell, M. (1998) Antiepileptic drug therapy. Clinical Techniques in Small Animal Practice, 13, 185192.
  • Potschka, H., Fischer, A., von Rüden, E.L., Hülsmeyer, V. & Baumgärtner, W. (2013) Canine epilepsy as a translational model? Epilepsia, 54, 571579.
  • Rieck, S., Rundfeldt, C. & Tipold, A. (2006) Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot trial. The Veterinary Journal, 172, 8695.
  • Rostock, A., Tober, C., Dost, R. & Bartsch, R. (1998a) Anxiolytic effects without sedation and amnesia of AWD 131-138 in animals. A comparison with diazepam and buspirone. Naunyn-Schmiedeberg's Archives of Pharmacology, 357 (Suppl. 4), R97.
  • Rostock, A., Tober, C., Dost, R. & Bartsch, R. (1998b) AWD 131-138 is a potential novel anxiolytic without sedation and amnesia: a comparison with diazepam and buspirone. Naunyn-Schmiedeberg's Archives of Pharmacology, 358(Suppl. 1), P35.
  • Rostock, A., Tober, C., Dost, R. & Bartsch, R. (1998c) AWD 131-138: anxiolytic and anticonvulsant activities without side effects in animals. Behavioural Pharmacology, 9(Suppl. 1), 79.
  • Rostock, A., Tober, C., Dost, R., Rundfeldt, C., Bartsch, R., Egerland, U., Stark, B., Schupke, H., Kronbach, T., Lankau, H.J., Unverferth, K. & Engel, J. (1998d) AWD 131-138. Drugs of the Future, 23, 253255.
  • Rundfeldt, C. & Löscher, W. (2014) The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy. CNS Drugs, 28, 2943.
  • Rundfeldt, C., Gasparic, A. & Wlaz, P. (2014) Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs. Journal of Veterinary Pharmacology and Therapeutics, 37, 421434.
  • Schmidt, D., Kupferberg, H.J., Yonekawa, W. & Penry, J.K. (1978) Development of tolerance of phenobarbital after administration over several days. Arzneimittelforschung (Drug Research), 28, 15151516.
  • Schwartz-Porsche, D., Löscher, W. & Frey, H.H. (1985) Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacological Therapy, 8, 113119.
  • Shihab, N., Bowen, J. & Volk, H.A. (2011) Behavioral changes in dogs associated with the development of idiopathic epilepsy. Epilepsy & Behavior, 21, 160167.
  • Sigel, E., Baur, R., Netzer, R. & Rundfeldt, C. (1998) The antiepileptic drug AWD 131-138 stimulates different recombinant isoforms of the rat GABA(A) receptor through the benzodiazepine binding site. Neuroscience Letters, 245, 8588.
  • Smith, P.M., Talbot, C.E. & Jeffery, N.D. (2008) Findings on low-field cranial MR images in epileptic dogs that lack interictal neurological deficits. The Veterinary Journal, 176, 320325.
  • Steinmetz, S., Tipold, A. & Löscher, W. (2013) Epilepsy after head injury in dogs: a natural model of posttraumatic epilepsy. Epilepsia, 54, 580588.
  • Thomas, W.B. & Dewey, C.W. (2008). Seizures and narcolepsy. In A Practical Guide to Canine and Feline Neurology. Ed Dewey, C.W., pp. 237259. Wiley Blackwell, Hoboken, NJ.
  • Trepanier, L.A., Van Schoick, A., Schwark, W.S. & Carrillo, J. (1998) Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association, 213, 14491453.
  • Wiglusz, M.S., Cubała, W.J., Gałuszko-Węgielnik, M., Jakuszkowiak-Wojten, K. & Landowski, J. (2012) Mood disorders in epilepsy - diagnostic and methodological considerations. Psychiatria Danubina, 24(Suppl. 1), S44S50.
  • Wismer, T.A. (2002) Accidental ingestion of alprazolam in 415 dogs. Veterinary and Human Toxicology, 44, 2223.